Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05552547 · ClinicalTrials.gov registry record · NA
Home BP Monitoring
A NA study of High Blood Pressure, sponsored by University Hospitals Cleveland Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 750
- Enrollment target
- 1
- Study location
NCT05552547: Recruiting NA study of High Blood Pressure, sponsored by University Hospitals Cleveland Medical Center.
NCT05552547 is a NA study of High Blood Pressure that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 750 participants, above the 472-participant average among 23 other High Blood Pressure trials with a reported enrollment target (59% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05552547, a NA study of High Blood Pressure, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 750 participants
- Enrollment target
- 1
- Study location
Study Summary
Most cases of high blood pressure in teens are missed for a number of reasons. One reason is that the most common way to make a diagnosis is to make three or more blood pressure measurements in a doctor's office on separate days. This can be inconvenient. Also, measuring blood pressure in the office might be inaccurate, since children (including teens) might have high values in the office but normal values at home. For these reasons, investigators wish to study a different way to identify teens with high blood pressure. Home BP measurements have been used in Europe to make a diagnosis, but not yet in the United States, and never in a higher risk population of teens. African American teens are at higher risk for high blood pressure than other teens. Investigators will compare the values received from the home BP machines to another method (24 hour ambulatory BP monitoring or ABPM) which is the best standard for diagnosis. Investigators also want to learn more about participants experience and their child's experience with both methods. A small sample of participating teens and parents will be invited to participate in short telephone interviews. This study plans to enroll a total of 750 teens at UH. Recruitment will not take place from other organizations.
Conditions Studied
Interventions
- DEVICE Home Blood Pressure Machine
- DEVICE 24-Hour Blood Pressure Machine
Study Locations (1)
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT05552547 shows while recruiting
NCT05552547 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 472-participant average among 23 other High Blood Pressure trials with a reported enrollment target (59% higher).
The record links to 1 condition, with High Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Home Blood Pressure Machine is the first listed.
NCT05552547 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05552547 about?
NCT05552547 is a clinical study titled "Home BP Monitoring". Most cases of high blood pressure in teens are missed for a number of reasons. One reason is that the most common way to make a diagnosis is to make three or more blood pressure measurements in a doctor's office on separate days. This can be inconvenient. Also, measuring blood pressure in the office...
What is the current status of trial NCT05552547?
This trial is currently recruiting. It is a NA study. The enrollment target is 750 participants. The study started on 2023-10-01. Estimated completion is 2026-09-30.
What conditions does trial NCT05552547 study?
This clinical trial studies the following conditions: High Blood Pressure.
What interventions are being tested in trial NCT05552547?
The interventions under investigation include: Home Blood Pressure Machine (DEVICE), 24-Hour Blood Pressure Machine (DEVICE).
Who is sponsoring clinical trial NCT05552547?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05552547 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for High Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05552547's enrollment target sits among peer trials
750 4th of 23 higher than 20 of 23 other High Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other High Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Addressing Hypertension Care in Africa Program
RECRUITING · NA
-
Blood Pressure Care for Advancing Real-World Evidence (BPCARE)
RECRUITING · NA
-
A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities
RECRUITING · NA
-
Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region Project 1 - Epidemiology (ACHIEVE P1-EPI)
RECRUITING · NA
-
CardioCare Quest: A Co-created Game for Improving Hypertension Treatment Compliance in Arizona
RECRUITING · NA
-
Delta GREENS Food is Medicine Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI